Amlodipine Benzoate is Used for managing hypertension and angina. It was first introduced by Azurity Pharmaceuticals Inc in its drug Katerzia on Jul 8, 2019. 2 different companies have introduced drugs containing Amlodipine Benzoate.

Amlodipine Benzoate Patents

Given below is the list of patents protecting Amlodipine Benzoate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Katerzia	US10799453	Amlodipine formulations	Apr 11, 2039	Azurity
Katerzia	US10695329	Amlodipine formulations	Oct 16, 2037	Azurity
Katerzia	US10894039	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US10952998	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US10959991	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US11364230	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US11471409	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US11484498	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US11701326	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US11918685	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US12053461	Amlodipine formulations	Oct 06, 2037	Azurity
Katerzia	US12336984	Amlodipine formulations	Oct 06, 2037	Azurity

Add above patents to watchlist

Amlodipine Benzoate's Family Patents

Full family tree

Amlodipine Benzoate Generic API Manufacturers

Only one generic application has been filed for Amlodipine Benzoate.

Given below is the list of companies who have filed for Amlodipine Benzoate generic, along with the locations of their manufacturing plants worldwide.